↓ Skip to main content

Dove Medical Press

Rationale for Lung Adenocarcinoma Prevention and Drug Development Based on Molecular Biology During Carcinogenesis

Overview of attention for article published in OncoTargets and therapy, April 2020
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
1 X user

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
17 Mendeley
Title
Rationale for Lung Adenocarcinoma Prevention and Drug Development Based on Molecular Biology During Carcinogenesis
Published in
OncoTargets and therapy, April 2020
DOI 10.2147/ott.s248436
Pubmed ID
Authors

Hongming Zhang, Liting Guo, Jibei Chen

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 24%
Student > Bachelor 1 6%
Student > Doctoral Student 1 6%
Student > Master 1 6%
Student > Ph. D. Student 1 6%
Other 0 0%
Unknown 9 53%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 18%
Medicine and Dentistry 3 18%
Agricultural and Biological Sciences 1 6%
Unknown 10 59%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 April 2020.
All research outputs
#17,458,546
of 25,611,630 outputs
Outputs from OncoTargets and therapy
#1,153
of 3,013 outputs
Outputs of similar age
#255,628
of 397,726 outputs
Outputs of similar age from OncoTargets and therapy
#23
of 85 outputs
Altmetric has tracked 25,611,630 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,013 research outputs from this source. They receive a mean Attention Score of 3.0. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 397,726 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 85 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.